Treatment of mycotic aortic aneurysms with endoluminal grafts.
OBJECTIVE
To report the benefit of endoluminal repair of mycotic aortic aneurysms and highlight the need for a registry.


METHODS
Nine patients (five female) were identified over 5 years (1998-2003) as having presumed mycotic aortic aneurysms (12 in total) suitable for endoluminal grafting. A total of nine thoracic and three abdominal were grafted and followed up for a median of 36 months.


RESULTS
Six of the aneurysms have resolved and one was converted to an open repair. There was one early death from rupture of a second undiagnosed aneurysm and two late deaths from rupture due to persistent inflammation. Long-term antibiotics have not been mandatory to ensure survival.


CONCLUSIONS
Mycotic aortic aneurysms of the thoracic and abdominal aorta do benefit from endoluminal repair, particularly when arising in previously normal aortic tissue. Endoluminal grafting also has a role in the palliation of secondarily infected aortas and so to prove its efficacy in the treatment of all these rare cases a registry is required.
Jones
K G
KG
Department of Vascular Surgery, Guy's and St Thomas' Hospital, London SE1 7EH, UK.
Bell
R E
RE
Sabharwal
T
T
Aukett
M
M
Reidy
J F
JF
Taylor
P R
PR
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017541:Aneurysm, False / Q000382:microbiology / Q000401:mortality / Q000628:therapy*; D000785:Aneurysm, Infected / Q000401:mortality / Q000628:therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001014:Aortic Aneurysm / Q000382:microbiology / Q000401:mortality / Q000628:therapy*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015607:Stents; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents